Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies.
Xinyue ChenQi CaiRuikai LiangDeju ZhangXiao LiuMeiying ZhangYan XiongMinxuan XuQi LiuPengyang LiPeng YuAo ShiPublished in: Cell death & disease (2023)
Copper is a vital mineral, and an optimal amount of copper is required to support normal physiologic processes in various systems, including the cardiovascular system. Over the past few decades, copper-induced cell death, named cuproptosis, has become increasingly recognized as an important process mediating the pathogenesis and progression of cardiovascular disease (CVD), including atherosclerosis, stroke, ischemia-reperfusion injury, and heart failure. Therefore, an in-depth understanding of the regulatory mechanisms of cuproptosis in CVD may be useful for improving CVD management. Here, we review the relationship between copper homeostasis and cuproptosis-related pathways in CVD, as well as therapeutic strategies addressing copper-induced cell death in CVD.
Keyphrases
- cell death
- cardiovascular disease
- oxide nanoparticles
- heart failure
- high glucose
- diabetic rats
- ischemia reperfusion injury
- type diabetes
- atrial fibrillation
- drug induced
- oxidative stress
- cell cycle arrest
- coronary artery disease
- left ventricular
- optical coherence tomography
- transcription factor
- subarachnoid hemorrhage
- cardiac resynchronization therapy